Skip to main content
Log in

Biological evaluation of undifferentiated carcinoma of the esophagus

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Patients with undifferentiated carcinoma of the esophagus (UEC) are rare and have a poor prognosis compared with those with differentiated squamous cell carcinomas (DECs). We compared clinicopathological and biological features of UEC and DEC, with emphasis on markers for epithelial cell origin, proliferation, and cell-cell adhesion.

Methods

Seven patients with UEC were compared with 21 with DEC. Immunohistochemical studies were performed by using monoclonal antibodies to cytokeratin, epithelial membrane antigen, p53, p21WAF1/CIP1, Ki-67, E-cadherin, desmoglein-1, and thrombomodulin.

Results

Patients with UEC had a poorer prognosis because of hematogenous metastasis at the time of presentation (mean survival, 6.5±6.2 vs. 35.5±28.9 months;P<.05). Immunohistochemical findings for cytokeratin and epithelial membrane antigen suggest that some UECs had epithelial origins. The following immunohistochemical profile of UEC was consistent with its highly malignant properties: (1) reduced or negative expression of cell-cell adhesion molecules such as E-cadherin, desmoglein-1, and thrombomodulin, (2) high positive rate for p53 and Ki-67, and (3) negative expression of p21WAF1/CIP1.

Conclusions

The immunohistochemical findings for UEC showed its high cell-proliferative activity and a high potential for metastasis. Clinical features of UEC were supported by the results of immunohistochemical findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Thomas P, Battifora H. Keratins versus epithelial membrane antigen in tumor diagnosis: an immunohistochemical comparison of five monoclonal antibodies.Hum Pathol 1987:18:728–34.

    PubMed  CAS  Google Scholar 

  2. Marshall CJ. Tumor suppressor gene.Cell 1991;254:313–26.

    Article  Google Scholar 

  3. Vogelstein B, Kinzler KW. p53 function and dysfunction.Cell 1992;70:523–6.

    Article  PubMed  CAS  Google Scholar 

  4. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K. p53 mutations in human cancer.Science 1991;253:49–53.

    Article  Google Scholar 

  5. Momand J, Zambetti GP, Olson DC, George D, Levine AJ. The mmd-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.Cell 1992;69:1237–45.

    Article  PubMed  CAS  Google Scholar 

  6. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.Int J Cancer 1983;31:13–20.

    PubMed  CAS  Google Scholar 

  7. Lam KY, Law SY, So MK, Fok M, Ma LT, Wong J. Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous carcinoma.Cancer 1996;77:7–13.

    Article  PubMed  CAS  Google Scholar 

  8. Chino O, Makuuchi H, Shimada H, Machimura T, Mitomi T, Osamura RY. Assessment of the proliferative activity of superficial esophageal carcinoma using MIB-1 immunostaining for the Ki-67 antigen.J Surg Oncol 1998;67:18–24.

    Article  PubMed  CAS  Google Scholar 

  9. El-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression.Cell 1993;75:817–25.

    Article  PubMed  CAS  Google Scholar 

  10. Shiozaki H, Oka H, Inoue M, Tamura S, Monden M. E-Cadherin mediated adhesion system in cancer cells.Cancer 1996;77:1605–13.

    PubMed  CAS  Google Scholar 

  11. Natsugoe S, Aikou T, Shimada M, et al. Expression of desmoglein 1 in squamous cell carcinoma of the esophagus.J Surg Oncol 1994;57:105–10.

    PubMed  CAS  Google Scholar 

  12. Maruyama I, Bell CE, Majerus PW. Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta.J Cell Biol 1985;101:363–71.

    Article  PubMed  CAS  Google Scholar 

  13. Tezuka Y, Yonezawa S, Maruyama I, et al. Expression of thrombomodulin in esophageal squamous cell carcinoma and its relationship to lymph node metastasis.Cancer Res 1995;55:4196–200.

    PubMed  CAS  Google Scholar 

  14. McKeown F. Oat-cell carcinoma of the esophagus.J Pathol Bacteriol 1952;64:889–91.

    Article  PubMed  CAS  Google Scholar 

  15. McCullen M, Vyas SK, Winwood PJ, Loehry CA, Parham DM, Hamblin T. Long-term survival associated with metastatic small cell carcinoma of the esophagus treated by chemotherapy, autologous bone marrow transplantation, and adjuvant radiation therapy.Cancer 1994;73:1–4.

    Article  PubMed  CAS  Google Scholar 

  16. Basher MA, Hulya L, Hwajalee R. Small cell carcinoma of the esophagus: report of three cases and review of the literature.Dig Dis Sci 1990;35:145–52.

    Article  Google Scholar 

  17. Simon Ying-Kit L, Manson F, King-Yin L. Small cell carcinoma of the esophagus.Cancer 1994;73:2894–9.

    Article  Google Scholar 

  18. Isolauri J, Mattila J, Kallioniemi OP. Primary undifferentiated small cell carcinoma of the esophagus: clinicopathological and flow cytometric evaluation of eight cases.J Surg Oncol 1991;46: 174–7.

    PubMed  CAS  Google Scholar 

  19. Kevin LB, John BM, Alberto AD. Primary small cell carcinoma of the esophagus.J Clin Gastroenterol 1991;13:135–41.

    Google Scholar 

  20. Tateishi R, Taniguchi H, Horai T, Iwanaga T, Taniguchi H. Argyrophil cell carcinoma (apudoma) of the esophagus: a histopathologic entity.Virchows Arch A Pathol Anat Histopathol 1976;371:283–94.

    Article  CAS  Google Scholar 

  21. Mori M, Matsukuma A, Adachi Y, et al. Small cell carcinoma of the esophagus.Cancer 1989;63:564–73.

    Article  PubMed  CAS  Google Scholar 

  22. Nishimaki T, Suzuki T, Nakagawa S, Watanabe K, Aizawa K, Hatakeyama K. Tumor spread and outcome of treatment in primary esophageal small cell carcinoma.J Surg Oncol 1997;64:130–4.

    Article  PubMed  CAS  Google Scholar 

  23. Tateishi R, Taniguchi H, Wada A, Horai T, Taniguchi K. Argyrophil cells and melanocytes in esophageal mucosa.Arch Pathol 1974;98:87–9.

    PubMed  CAS  Google Scholar 

  24. Ho KJ, Herrera GA, Jones JM, Alexander CB. Small cell carcinoma of the esophagus: evidence for a unified histogenesis.Hum Pathol 1984;15:460–8.

    PubMed  CAS  Google Scholar 

  25. Hollstein C, Metcalf RA, Welsh JA, Montesano R, Harris CC. Frequent mutation of thep53 gene in human esophageal cancer.Proc Natl Acad Sci USA 1990;87:9958–61.

    Article  PubMed  CAS  Google Scholar 

  26. Imazeki F, Omata M, Nose H, Ohto M, Isono K.p53 gene mutations in gastric and esophageal cancers.Gastroenterology 1992;103:892–6.

    PubMed  CAS  Google Scholar 

  27. Coggi G, Bosari S, Roncalli M, et al. p53 protein accumulation and p53 gene mutation in esophageal carcinoma: a molecular and immunohistochemical study with clinicopathologic correlations.Cancer 1997;79:425–32.

    Article  PubMed  CAS  Google Scholar 

  28. Parenti AR, Rugge M, Frizzera E, et al. p53 overexpression in the multistep process of esophageal carcinogenesis.Am J Surg Pathol 1995;19:1418–22.

    Article  PubMed  CAS  Google Scholar 

  29. Cooper K, Taylor L. p53 protein expression and integrated HPV DNA are not mutually exclusive in esophageal cancer.Cell Vision 1995;2:49–51.

    Google Scholar 

  30. Nakamura T, Ide H, Eguchi R, et al. Expression of p53 protein related to human papilloma virus and DNA ploidy in superficial esophageal carcinoma.Surg Today 1995;25:591–7.

    Article  PubMed  CAS  Google Scholar 

  31. Baron PL, Gates CE, Reed CE, et al. p53 overexpression in squamous cell carcinoma of the esophagus.Ann Surg Oncol 1997; 4:37–45.

    Article  PubMed  CAS  Google Scholar 

  32. Goukon Y, Sasano H, Nishihira T, Mori S, Nagura H. p53 immunolocalization in cytology specimens: a study in human esophageal carcinoma.Diagn Cytopathol 1994;11:113–8.

    PubMed  CAS  Google Scholar 

  33. Shimaya K, Shiozaki H, Inoue M, et al. Significance of p53 expression as a prognostic factor in esophageal squamous cell carcinoma.Virchows Arch A Pathol Anat Histopathol 1993;422: 271–6.

    Article  PubMed  CAS  Google Scholar 

  34. Sugimachi K, Kitamura K, Matsuda H, Mori M, Kuwano H, Ide H. Proposed new criteria for early carcinoma of the esophagus.Surg Gynecol Obstet 1991;173:303–8.

    PubMed  CAS  Google Scholar 

  35. Yoshinaka H, Shimazu H, Fukumoto T, Baba M. Superficial esophageal carcinoma: a clinicopathological review of 59 cases.Am J Gastroenterol 1991;86:1413–8.

    PubMed  CAS  Google Scholar 

  36. Sarbia M, Porschen R, Borchard F, Horstmann O, Willers R, Gabbert HE. p53 protein expression in squamous cell carcinoma.Cancer 1994;74:2218–23.

    Article  PubMed  CAS  Google Scholar 

  37. Wang DY, Xiang YY, Tanaka M, et al. High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China, and its relationship to progression and prognosis.Cancer 1994;74:3089–96.

    Article  PubMed  CAS  Google Scholar 

  38. Monges GM, Seitz JF, Giovannini MF, Gouvernet JM, Torrente MA, Hassoun JA. Prognostic value of p53 protein expression in squamous cell carcinoma of the esophagus.Cancer Detect Prev 1996;20:63–7.

    PubMed  CAS  Google Scholar 

  39. Chanvitan A, Nekarda H, Casson AG. Prognostic value of DNA index, S-shape fraction and p53 protein accumulation after surgical resection of esophageal squamous cell carcinoma in Thailand.Int J Cancer 1995;63:381–6.

    PubMed  CAS  Google Scholar 

  40. Takubo K, Nakamura K, Sawabe M, et al. Primary undifferentiated small cell carcinoma of the esophagus.Hum Pathol 1999;30:216–21.

    Article  PubMed  CAS  Google Scholar 

  41. Okudela K, Ito T, Kameda Y, Nakamura N, Kitamura H. Immunohistochemical analysis for cell proliferation-related protein expression in small cell carcinoma of the esophagus: a comparative study with small cell carcinoma of the lung and squamous cell carcinoma of the esophagus.Histol Histopathol 1999;14:479–85.

    PubMed  CAS  Google Scholar 

  42. Doki Y, Shiozaki H, Tahara H, et al. Correlation between E-cadherin expression and invasiveness in vitro in a human esophageal cancer cell line.Cancer Res 1993;53:3421–6.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matsumoto, M., Natsugoe, S., Nakashima, S. et al. Biological evaluation of undifferentiated carcinoma of the esophagus. Annals of Surgical Oncology 7, 204–209 (2000). https://doi.org/10.1007/BF02523655

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02523655

Key Words

Navigation